Publications by authors named "Christopher Brain"

Claim this Profile
I
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition.
Anne Fassl, Christopher Brain, Monther Abu-Remaileh, Iga Stukan, Deborah Butter

Sci Adv· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.
Sunkyu Kim, Ralph Tiedt, Alice Loo, Thomas Horn, Scott Delach, Christopher Brain

Oncotarget· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potent and selective cyclin-dependent kinases 4 and 6 inhibitor ribociclib (LEE011) is a versatile combination partner in preclinical cancer models.
Sunkyu Kim, Ralph Tiedt, Alice Loo, Thomas Horn, Scott Delach, Christopher Brain

Oncotarget· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative effects of CDK4/6 inhibition in CDK4-amplified human liposarcoma in vitro and in vivo.
Yi-Xiang Zhang, Ewa Sicinska, Jeffrey T Czaplinski, Stephen P Remillard, Samuel Moss, Christopher Brain

Mol Cancer Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An effective prodrug strategy to selectively enhance ocular exposure of a cannabinoid receptor (CB1/2) agonist.
Nello Mainolfi, James Powers, Jakal Amin, Debby Long, Wendy Lee, Christopher Brain

J Med Chem· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.
Young Shin Cho, Hayley Angove, Christopher Brain, Christine Hiu-Tung Chen, Hong Cheng

ACS Med Chem Lett· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.
Young Shin Cho, Maria Borland, Christopher Brain, Christine H-T Chen, Hong Cheng

J Med Chem· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
Andrew G Cole, Axel Metzger, Marc-Raleigh Brescia, Lan-Ying Qin, Kenneth C Appell, Christopher T Brain

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration.
Edward K Dziadulewicz, Stuart J Bevan, Christopher T Brain, Paul R Coote, Andrew J Culshaw

J Med Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
Alex Dyson, Marcus Peacock, Alice Chen, Jean-Philippe Courade, Mohammed Yaqoob, Christopher Brain

Pain· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An improved procedure for the synthesis of benzimidazoles, using palladium-catalyzed aryl-amination chemistry.
Christopher T Brain, James T Steer

J Org Chem· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis